Edition:
United Kingdom

NewLink Genetics Corp (NLNK.OQ)

NLNK.OQ on NASDAQ Stock Exchange Global Market

1.52USD
18 Jan 2019
Change (% chg)

$0.01 (+0.66%)
Prev Close
$1.51
Open
$1.51
Day's High
$1.53
Day's Low
$1.50
Volume
55,116
Avg. Vol
100,284
52-wk High
$9.14
52-wk Low
$1.28

Chart for

About

NewLink Genetics Corporation is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $387.58
Shares Outstanding(Mil.): 36.22
Dividend: --
Yield (%): --

Financials

  NLNK.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -2.29 -- --
ROI: -50.00 8.99 14.48
ROE: -52.94 10.13 15.99

Earnings vs. Estimates